-
Signature
-
By: /s/ Christine Bellon, Attorney-in-fact
-
Stock symbol
-
BEAM
-
Transactions as of
-
Jul 1, 2025
-
Transactions value $
-
-$23,962
-
Form type
-
4
-
Date filed
-
7/3/2025, 05:30 PM
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Simon Amy |
Chief Medical Officer |
C/O BEAM THERAPEUTICS INC.,, 238 MAIN STREET, CAMBRIDGE |
By: /s/ Christine Bellon, Attorney-in-fact |
2025-07-03 |
0001963879 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
BEAM |
Common Stock |
Sale |
-$6.34K |
-374 |
-0.57% |
$16.94 |
65.7K |
Jul 1, 2025 |
Direct |
F1, F2 |
| transaction |
BEAM |
Common Stock |
Sale |
-$17.6K |
-876 |
-1.33% |
$20.12 |
64.9K |
Jul 3, 2025 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: